Rammurti T Kamble

Dr. Rammurti T Kamble is a Professor of Medicine in Hematology-Oncology and Cell and Gene Therapy at Baylor College of Medicine and Houston Methodist Hospital, with clinical and research expertise in hematologic malignancies and hematopoietic stem cell transplantation. His work focuses on multiple myeloma, graft-versus-host disease (GVHD), and innovative transplant protocols.

• MD from P.J. Nehru Medical College, Raipur, India (1986, gold medal)
• Residency at University of Tennessee College of Medicine, Memphis, TN
• Fellowships in Hematology-Oncology at All India Institute of Medical Sciences, New Delhi; University of Oklahoma Health Science Center; and New York Hospital-Cornell Medical Center

Dr. Kamble’s research interests span:

• Hematologic malignancies (multiple myeloma, lymphoma)
• Hematopoietic stem cell transplantation
• Molecular mechanisms of leukemia
• Innovative reduced-intensity conditioning protocols
• In vivo T-cell depletion
• Graft-versus-host disease management

His publications highlight trends in:

• Stem cell transplantation outcomes
• Multiple myeloma therapeutic approaches
• Graft-versus-host disease complications
• Role of molecular markers in hematologic cancers
• Pharmacological interventions in transplant patients
• Post-transplant infections (e.g., HHV-6)

Scientific awards include:

• Union against Cancer (ICRETT, Geneva) award (1994)
• Central Science and Industrial Research (CSIR) award (1995)

Dr. Kamble is board-certified in Internal Medicine and Medical Oncology, with affiliations to the Center for Gene Therapy and the Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine. He reviews manuscripts for journals like Blood and Biology of Bone Marrow Transplantation.